VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2022-07-05−357→ 126,347 total(indirect: by CLAT) - Gift
Common Stock
2022-10-03−304→ 126,043 total(indirect: by CLAT) - Tax Payment
Common Stock
2022-12-09$753.28/sh−57$42,937→ 322,432 total - Gift
Common Stock
2022-05-24−23,077→ 322,489 total - Gift
Common Stock
2022-04-06−302→ 126,704 total(indirect: by CLAT)
Holdings
- 2,102(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.